Lv6
1655 积分 2022-04-04 加入
US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®)
13天前
已完结
Ceftazidime/avibactam for the treatment of bloodstream infection due to carbapenemase-producing Enterobacterales in onco-haematologic neutropenic patients (the TARZAN study)
13天前
已完结
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
13天前
已完结
Cefiderocol Pharmacokinetics in Critically-ill Patients Receiving Extra-Corporeal Membrane Oxygenation (ECMO)
23天前
已完结
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases
1个月前
已完结
中国九城市成人医院获得性肺炎微生物学与临床特点调查
1个月前
已完结
中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)
1个月前
已完结
Mechanosensing Pathways in the Progression of Pulmonary Fibrosis
2个月前
已完结
Pharmacokinetics and Biotransformation of Mirtazapine in Human Volunteers
2个月前
已完结
Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: A pilot study
2个月前
已完结
皖公网安备34019202002308
